ÂÜÀòÂÒÂ×

Therese Kallur is an accomplished professional in the biotechnology sector, currently serving as CSO and VP of Business Development at BioLamina Inc. since November 2010. At BioLamina, a Swedish biotechnology company specializing in matrix biology and cell culture, Therese has played a vital role in strategic product development and scientific collaborations, with a focus on neural and clinical cell therapy markets. Previous positions held include Director of Business Development, Business Development Manager, and Commercial Project Manager, all emphasizing product management and development. Therese's academic background includes a PhD in Neurology and a Master's in Molecular Biology and Neuroscience from Lund University, supplemented by a Bachelor's in Psychology. Prior experience includes postdoctoral research at the Max Planck Institute for Biology of Ageing and a PhD at the Stem Cell Center at Lund University.